Pricing Log in Create free account
Friday 6 November 2026 Export HLN’s income statement to Excel — free account

Haleon PLC Sponsored ADR

HLN Healthcare Drug Manufacturers Specialty & Generic

Haleon PLC Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $14.5 billion, up 1.33% from fiscal 2024.

9.13 0.10 −1.08%
Market cap
$40.2B
P/E
20.5×
Fwd P/E
16.5×
Dividend yield
2.16%
F-score
8/9
Altman Z
3.04
Beneish M
−2.60
Dividend safety
63/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Haleon PLC Sponsored ADR (HLN) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Haleon PLC Sponsored ADR (HLN) trades at a EV/EBITDA of 12.2×. Over the past ten years it has ranged from 0.0× (March 2024) to 14.8× (June 2025); the current reading is higher than 46% of that period. That is in line with the Drug Manufacturers Specialty & Generic industry median of 12.2× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 13.4× 4.66%
FY2024 12.8× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period EV/EBITDA Change
Sep 2024 13.9× 13.80%
Mar 2024 12.2× —
Sep 2023 0.0× —
Jun 2023 0.0× —
1 more quarters

Against its own ten years

Low 0.0× High 14.8×
Ten-year median 12.3×
Current reading's percentile 46

EV/EBITDA against peers

Company EV/EBITDA
ZTS Zoetis Inc. compare 10.7×
TAK Takeda Pharmaceutical Co. compare 11.2×
HLN Haleon PLC Sponsored ADR 12.2×
VTRS Viatris Inc. compare 12.3×
UTHR United Therapeutics Corporation compare 14.7×
NBIX Neurocrine Biosciences, Inc. compare 16.5×
ELAN Elanco Animal Health Incorporated compare 19.7×
RDY Dr. Reddy's Laboratories Ltd compare 22.9×
TEVA Teva Pharmaceutical Industries Ltd. compare 26.2×
Drug Manufacturers Specialty & Generic industry median 12.2×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on HLN